The Affiliated Hospital Of Hangzhou Normal University
Clinical trials sponsored by The Affiliated Hospital Of Hangzhou Normal University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a phone app tame fatty liver? 2,000 patients put to the test Results expected Jul 2027 (estimated)
- Zapping the brain to heal the liver: new trial tests TMS for fatty liver Results expected Aug 2027 (estimated)
-
Can a phone app tame fatty liver? 2,000 patients put to the test
Disease control Recruiting nowThis study tests a digital app that helps doctors guide patients with metabolic fatty liver disease (MAFLD) through diet and exercise plans. Researchers will enroll 2,000 adults aged 18–65 with a BMI of 24–35 and a confirmed MAFLD diagnosis. Participants use the app to track weig…
Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
20,000 seniors join quest to unlock fatty liver secrets
Knowledge-focused Recruiting nowThis study will follow 20,000 elderly people with fatty liver disease to learn what factors affect their health. Researchers will look at lifestyle, genetics, and environment to understand how the disease progresses. The goal is to create better risk assessment tools and preventi…
Sponsor: The Affiliated Hospital of Hangzhou Normal University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC